Role of Aviptadil in COVID-19

Aviptadil in COVID-19

Authors

  • AV Raveendran Assistant Professor of Medicine (Former) Govt. Medical College,Manjeri,Kottayam, Kozhikode, Kerala, India. Specialist in internal medicine Badr Al Samaa, Barka, Sultanate of Oman
  • Khalid Salim Al Dhuhli
  • G Harish Kumar

Abstract

COVID-19 pandemic resulted in large number of death worldwide. Search for effective prevention and treatment option is still evolving. Aviptadil, is a synthetic form of Human Vasoactive Intestinal Polypeptide (VIP) tried in the treatment of COVID-19. It is available for inhalational and intra venous use.  Treatment with Aviptadil showed promising results in  Corona virus infected critically ill patients.

Published

2021-01-30

Issue

Section

Special Article